Trademarkia Logo

Canada

C$
Trademark Search in Canada
XERIJECT

View On IC.GC.CA

XERIJECT
APPROVED

on 14 Apr 2025

Last Applicant/ Owned by

Xeris Pharmaceuticals, Inc.

180 N LaSalle Street, Suite 1810Chicago IL 60601

US

Serial Number

2385435 filed on 3rd Jun 2021

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

CA

K1P1J9

XERIJECT

Trademark usage description

pharmaceutical preparations for the treatment of diseases and conditions, namely, alimentary tract, metabolic, oncologic, autoimmune, and nervous syst Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of diseases and conditions, namely, alimentary tract, metabolic, oncologic, autoimmune, and nervous system diseases and conditions; pharmaceutical preparations for the treatment of diseases and conditions, namely, anti-infectives to prevent or treat infectious diseases and conditions, human vaccines, antineoplastic pharmaceutical preparations for the treatment of cancer, and immunomodulating pharmaceutical preparations for the treatment of immune system related diseases and disorders.

Classification kind code

11

Mark Details

Serial Number

2385435

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 6th Mar 2023		Agent Changed
Submitted for opposition 22
on 9th Dec 2022		Search Recorded
Submitted for opposition 20
on 9th Dec 2022		Examiner's First Report
Submitted for opposition 223
on 9th Dec 2022		Total Provisional Refusal
Submitted for opposition 256
on 20th Jun 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 19th Aug 2021		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 19th Aug 2021		Formalized
Submitted for opposition 1
on 19th Aug 2021		Created
Submitted for opposition 228
on 3rd Jun 2021		International Registration
Submitted for opposition 30
on 3rd Jun 2021		Filed